Treatment with electrochemotherapy and tyrosine kinase inhibitors in a dog with an inoperable oral squamous cell carcinoma

被引:0
|
作者
Elisabetta Treggiari [1 ]
Emanuela Catania [1 ]
Ilaria Porcellato [2 ]
机构
[1] Oncopets ,Facoltà Di Medicina Veterinaria
[2] Università Di Perugia,undefined
[3] Servizio Di Patologia Veterinaria,undefined
来源
Veterinary Oncology | / 2卷 / 1期
关键词
Oral squamous cell carcinoma; Dog; Electrochemotherapy; Tyrosine kinase inhibitor;
D O I
10.1186/s44356-025-00019-2
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Concomitant oral tyrosine kinase inhibitors and bisphosphonates in advanced renal cell carcinoma with bone metastases
    Beuselinck, B.
    Wolter, P.
    Karadimou, A.
    Elaidi, R.
    Dumez, H.
    Rogiers, A.
    Van Cann, T.
    Willems, L.
    Body, J-J
    Berkers, J.
    Van Poppel, H.
    Lerut, E.
    Debruyne, P.
    Paridaens, R.
    Schoffski, P.
    BRITISH JOURNAL OF CANCER, 2012, 107 (10) : 1665 - 1671
  • [32] EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS IN ADVANCED SQUAMOUS CELL CARCINOMA OF THE LUNG.
    Ameratunga, Malaka
    Broad, Adam
    Pavlakis, Nick
    Gebski, Val
    Khasraw, Mustafa
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1189 - S1189
  • [33] Are tyrosine kinase inhibitors fit for purpose in the treatment of metastatic papillary renal cell carcinoma?
    Hemmant, Joshua
    Chow, Karyee
    JOURNAL OF CLINICAL UROLOGY, 2021, 14 (03) : 175 - 178
  • [34] Differential expression of the non-receptor tyrosine kinase BRK in oral squamous cell carcinoma and normal oral epithelium
    Petro, BJ
    Tan, RC
    Tyner, AL
    Lingen, MW
    Watanabe, K
    ORAL ONCOLOGY, 2004, 40 (10) : 1040 - 1047
  • [35] IMPACT OF TREATMENT WITH TYROSINE KINASE INHIBITORS ON BRAIN METASTASES FROM RENAL CELL CARCINOMA
    Bassanelli, M.
    Felici, A.
    Giacinti, S.
    Baldoni, A.
    Aschelter, A. M.
    Marchetti, P.
    ANTICANCER RESEARCH, 2013, 33 (05) : 2336 - 2337
  • [36] Tyrosine Kinase Inhibitors in the Treatment of Metastasised Renal Cell Carcinoma-Future or the Past?
    Michaelis, Jakob
    Grabbert, Markus
    Sigle, August
    Yilmaz, Mehmet
    Schlager, Daniel
    Gratzke, Christian
    Miernik, Arkadiusz
    Schoeb, Dominik Stefan
    CANCERS, 2022, 14 (15)
  • [37] Clinicopathologic evaluation of oral squamous cell carcinoma in a young dog
    Ozturk Gurgen, Hazal
    Egeden, Evrim
    Sennazli, Gulbin
    ANKARA UNIVERSITESI VETERINER FAKULTESI DERGISI, 2021, 68 (01): : 77 - 81
  • [38] Spleen tyrosine kinase as a novel candidate tumour suppressor gene for human oral squamous cell carcinoma
    Ogane, S.
    Onda, T.
    Takano, N.
    Yajima, T.
    Uchiyama, T.
    Shibahara, T.
    EJC SUPPLEMENTS, 2009, 7 (02): : 148 - 149
  • [39] Nerve Growth Factor and Tyrosine Kinase A Receptor in Oral Squamous Cell Carcinoma: Is There an Association With Perineural Invasion?
    Kolokythas, Antonia
    Cox, Darren P.
    Dekker, Nusi
    Schmidt, Brian L.
    JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2010, 68 (06) : 1290 - 1295
  • [40] Spleen tyrosine kinase as a novel candidate tumor suppressor gene for human oral squamous cell carcinoma
    Ogane, Satoru
    Oncla, Takeshi
    Takano, Nobuo
    Yajima, Tetsuo
    Uchiyama, Takeshi
    Shibahara, Takahiko
    INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (11) : 2651 - 2657